Korean J Pain.  2015 Jul;28(3):169-176. 10.3344/kjp.2015.28.3.169.

The Iceberg Nature of Fibromyalgia Burden: The Clinical and Economic Aspects

• Ghavidel-Parsa B
• Bidari A
• Amir Maafi A
• Ghalebaghi B

• KMID: 2149460
• DOI: http://doi.org/10.3344/kjp.2015.28.3.169

Abstract

This review has focused on important but less visible aspects of fibromyalgia (FM) with respect to the high impact of this disorder on patients and societies. FM is a common but challengeable illness. It is characterized by chronic widespread pain, which can be accompanied by other symptoms including fatigue, sleep disturbances, cognitive dysfunction, anxiety and depressive episodes. While our understanding of this debilitating disorder is limited, diagnosis and treatment of this condition is very difficult, even in the hands of experts. Due to the nature of disease, where patients experience invalidation by medical services, their families and societies regarding the recognition and management of disease, direct, indirect and immeasurable costs are considerable. These clinical and economic costs are comparable with other common diseases, such as diabetes, hypertension and osteoarthritis, but the latter usually receives much more attention from healthcare and non-healthcare resources. Present alarming data shows the grave and "iceberg-like" burden of FM despite the benign appearance of this disorder and highlights the urgent need both for greater awareness of the disease among medical services and societies, as well as for more research focused on easily used diagnostic methods and target specific treatment.

Keyword

Chronic pain; Cost of illness; Economics; Fibromyalgia; Musculoskeletal diseases; Pain

MeSH Terms

Anxiety
Chronic Pain
Cost of Illness
Delivery of Health Care
Diagnosis
Fatigue
Fibromyalgia*
Hand
Humans
Hypertension
Ice Cover*
Musculoskeletal Diseases
Osteoarthritis

Reference

1. Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007; 8:27. PMID: 17349056.

2. Schmidt-Wilcke T, Clauw DJ. Fibromyalgia: from pathophysiology to therapy. Nat Rev Rheumatol. 2011; 7:518–527. PMID: 21769128.

3. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990; 33:160–172. PMID: 2306288.

4. de Girolamo G. Epidemiology and social costs of low back pain and fibromyalgia. Clin J Pain. 1991; 7(Suppl 1):S1–S7. PMID: 1839774.

5. Goldenberg DL. Fibromyalgia syndrome. An emerging but controversial condition. JAMA. 1987; 257:2782–2787. PMID: 3553636.

6. Wolfe F, Cathey MA. Prevalence of primary and secondary fibrositis. J Rheumatol. 1983; 10:965–968. PMID: 6582268.

7. Bennett R. Fibromyalgia. In : Wall PD, Melzack R, editors. Textbook of pain. 4th ed. Edinburgh: Churchill-Livingstone;1999. p. 579–602.

8. Thomas E, Peat G, Harris L, Wilkie R, Croft PR. The prevalence of pain and pain interference in a general population of older adults: cross-sectional findings from the North Staffordshire Osteoarthritis Project (NorStOP). Pain. 2004; 110:361–368. PMID: 15275787.

9. Bidari A, Ghavidel-Parsa B, Ghalehbaghi B. Reliability of ACR criteria over time to differentiate classic fibromyalgia from nonspecific widespread pain syndrome: a 6-month prospective cohort study. Mod Rheumatol. 2009; 19:663–669. PMID: 19730972.

10. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010; 62:600–610. PMID: 20461783.

11. Wolfe F, Walitt B. Culture, science and the changing nature of fibromyalgia. Nat Rev Rheumatol. 2013; 9:751–755. PMID: 23820862.

12. Wolfe F, Brähler E, Hinz A, Häuser W. Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res (Hoboken). 2013; 65:777–785. PMID: 23424058.

13. Bidari A, Hassanzadeh M, Ghavidel Parsa B, Kianmehr N, Kabir A, Pirhadi S, et al. Validation of the 2010 American College of Rheumatology preliminary diagnostic criteria for fibromyalgia in an Iranian population. Rheumatol Int. 2013; 33:2999–3007. PMID: 23884705.

14. Kim SM, Lee SH, Kim HR. Applying the ACR preliminary diagnostic criteria in the diagnosis and assessment of fibromyalgia. Korean J Pain. 2012; 25:173–182. PMID: 22787548.

15. McBeth J, Mulvey MR. Fibromyalgia: mechanisms and potential impact of the ACR 2010 classification criteria. Nat Rev Rheumatol. 2012; 8:108–116. PMID: 22270077.

16. Berger A, Dukes E, Martin S, Edelsberg J, Oster G. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract. 2007; 61:1498–1508. PMID: 17655684.

17. Hudson JI, Goldenberg DL, Pope HG Jr, Keck PE Jr, Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med. 1992; 92:363–367. PMID: 1558082.

18. Hudson JI, Pope HG. The concept of affective spectrum disorder: relationship to fibromyalgia and other syndromes of chronic fatigue and chronic muscle pain. Baillieres Clin Rheumatol. 1994; 8:839–856. PMID: 7850883.

19. Robinson RL, Birnbaum HG, Morley MA, Sisitsky T, Greenberg PE, Claxton AJ. Economic cost and epidemiological characteristics of patients with fibromyalgia claims. J Rheumatol. 2003; 30:1318–1325. PMID: 12784409.

20. Berger A, Sadosky A, Dukes E, Martin S, Edelsberg J, Oster G. Characteristics and patterns of healthcare utilization of patients with fibromyalgia in general practitioner settings in Germany. Curr Med Res Opin. 2008; 24:2489–2499. PMID: 18664319.

21. Annemans L, Le Lay K, Taïeb C. Societal and patient burden of fibromyalgia syndrome. Pharmacoeconomics. 2009; 27:547–559. PMID: 19663526.

22. Annemans L, Wessely S, Spaepen E, Caekelbergh K, Caubère JP, Le Lay K, et al. Health economic consequences related to the diagnosis of fibromyalgia syndrome. Arthritis Rheum. 2008; 58:895–902. PMID: 18311794.

23. Buskila D, Neumann L, Sibirski D, Shvartzman P. Awareness of diagnostic and clinical features of fibromyalgia among family physicians. Fam Pract. 1997; 14:238–241. PMID: 9201499.

24. Perrot S, Schaefer C, Knight T, Hufstader M, Chandran AB, Zlateva G. Societal and individual burden of illness among fibromyalgia patients in France: association between disease severity and OMERACT core domains. BMC Musculoskelet Disord. 2012; 13:22. PMID: 22340435.

25. Boonen A, van den Heuvel R, van Tubergen A, Goossens M, Severens JL, van der Heijde D, et al. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis. Ann Rheum Dis. 2005; 64:396–402. PMID: 15271773.

26. Perrot S, Winkelmann A, Dukes E, Xu X, Schaefer C, Ryan K, et al. Characteristics of patients with fibromyalgia in France and Germany. Int J Clin Pract. 2010; 64:1100–1108. PMID: 20497264.

27. Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL, et al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum. 1997; 40:1560–1570. PMID: 9324009.

28. White KP, Nielson WR, Harth M, Ostbye T, Speechley M. Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample. J Rheumatol. 2002; 29:588–594. PMID: 11908578.

29. White LA, Birnbaum HG, Kaltenboeck A, Tang J, Mallett D, Robinson RL. Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss. J Occup Environ Med. 2008; 50:13–24. PMID: 18188077.

30. Chandran A, Schaefer C, Ryan K, Baik R, McNett M, Zlateva G. The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adults. J Manag Care Pharm. 2012; 18:415–426. PMID: 22839682.

31. Winkelmann A, Perrot S, Schaefer C, Ryan K, Chandran A, Sadosky A, et al. Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study. Appl Health Econ Health Policy. 2011; 9:125–136. PMID: 21332254.

32. Doron Y, Peleg R, Peleg A, Neumann L, Buskila D. The clinical and economic burden of fibromyalgia compared with diabetes mellitus and hypertension among Bedouin women in the Negev. Fam Pract. 2004; 21:415–419. PMID: 15249530.

33. Silverman S, Dukes EM, Johnston SS, Brandenburg NA, Sadosky A, Huse DM. The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis. Curr Med Res Opin. 2009; 25:829–840. PMID: 19220165.

34. Häuser W, Türp JC, Lempa M, Wesselmann U, Derra C. Functional somatic pain syndromes-nomenclature. Schmerz. 2004; 18:98–103. PMID: 15067528.

35. Arnold LM, Hudson JI, Keck PE, Auchenbach MB, Javaras KN, Hess EV. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry. 2006; 67:1219–1225. PMID: 16965199.

36. Choy E, Perrot S, Leon T, Kaplan J, Petersel D, Ginovker A, et al. A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Serv Res. 2010; 10:102. PMID: 20420681.

37. Busse JW, Kulkarni AV, Badwall P, Guyatt GH. Medically Unexplained Syndromes Study Group. Attitudes towards fibromyalgia: a survey of Canadian chiropractic, naturopathic, physical therapy and occupational therapy students. BMC Complement Altern Med. 2008; 8:24. PMID: 18513441.

38. Häuser W, Thieme K, Turk DC. Guidelines on the management of fibromyalgia syndrome - a systematic review. Eur J Pain. 2010; 14:5–10. PMID: 19264521.

39. McNett M, Goldenberg D, Schaefer C, Hufstader M, Baik R, Chandran A, et al. Treatment patterns among physician specialties in the management of fibromyalgia: results of a cross-sectional study in the United States. Curr Med Res Opin. 2011; 27:673–683. PMID: 21294700.

40. Hughes G, Martinez C, Myon E, Taïeb C, Wessely S. The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum. 2006; 54:177–183. PMID: 16385513.

41. Carville SF, Arendt-Nielsen L, Bliddal H, Blotman F, Branco JC, Buskila D, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008; 67:536–541. PMID: 17644548.

42. Kool MB, van Middendorp H, Boeije HR, Geenen R. Understanding the lack of understanding: invalidation from the perspective of the patient with fibromyalgia. Arthritis Rheum. 2009; 61:1650–1656. PMID: 19950317.

43. Blom D, Thomaes S, Kool MB, van Middendorp H, Lumley MA, Bijlsma JW, et al. A combination of illness invalidation from the work environment and helplessness is associated with embitterment in patients with FM. Rheumatology (Oxford). 2012; 51:347–353. PMID: 22096009.

44. Parrish BP, Zautra AJ, Davis MC. The role of positive and negative interpersonal events on daily fatigue in women with fibromyalgia, rheumatoid arthritis, and osteoarthritis. Health Psychol. 2008; 27:694–702. PMID: 19025264.

45. Arnold LM, Crofford LJ, Mease PJ, Burgess SM, Palmer SC, Abetz L, et al. Patient perspectives on the impact of fibromyalgia. Patient Educ Couns. 2008; 73:114–120. PMID: 18640807.

46. Ghavidel Parsa B, Amir Maafi A, Haghdoost A, Arabi Y, Khojamli M, Chatrnour G, et al. The validity and reliability of the Persian version of the Revised Fibromyalgia Impact Questionnaire. Rheumatol Int. 2014; 34:175–180. PMID: 24381091.

47. Ghavidel-Parsa B, Amir Maafi A, Aarabi Y, Haghdoost A, Khojamli M, Montazeri A, et al. Correlation of invalidation with symptom severity and health status in fibromyalgia. Rheumatology (Oxford). 2015; 54:482–486. PMID: 25205826.

48. Hoffman DL, Dukes EM. The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract. 2008; 62:115–126. PMID: 18039330.

49. Verbunt JA, Pernot DH, Smeets RJ. Disability and quality of life in patients with fibromyalgia. Health Qual Life Outcomes. 2008; 6:8. PMID: 18211701.

50. Wolfe F, Hawley DJ. Evidence of disordered symptom appraisal in fibromyalgia: increased rates of reported comorbidity and comorbidity severity. Clin Exp Rheumatol. 1999; 17:297–303. PMID: 10410262.

51. Hahn SR, Thompson KS, Wills TA, Stern V, Budner NS. The difficult doctor-patient relationship: somatization, personality and psychopathology. J Clin Epidemiol. 1994; 47:647–657. PMID: 7722577.